Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohor
Recruiting · NCT06076005 · Observational (researchers observe without assigning treatment) · Lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The distribution of demographic, clinical, radiological, pathological and molecular characteristics of lung cancer at the time of diagnosis, as well as preferential association between elements of those domains, have not been specifically studied in Italy. The aim of the present project is to assess, in a systematic fashion, the demographic, clinical, radiological, pathological and molecular characteristics of advanced lung cancer at the time of diagnosis in a large Italian cohort of consecutive patients referred to two tertiary referral centers.
Who can take part
Inclusion criteria
- Age \>18 years
- Suspicion of lung cancer based on imaging (CT and/or PET/CT)
- Indication to a biopsy for diagnosis, staging and/or molecular profiling
Exclusion criteria
- Inability or unwillingness to provide a written informed consent
- ECOG performance status (\>3) which makes a tissue diagnosis unfeasible
- ASA 4 status
- TNM Stage I-III
Where it is running
3 locations listed.
- Interventional Pulmonology Division - Fondazione Policlinico Universitario A. Gemelli IRCCS - Roma, Italy
- Istituto Nazionale Tumori Regina Elena - Roma, Italy
- Medical Oncology Division - Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Roma, Italy